Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

33818-15-4 - Cytidine-5'-diphosphocholine sodium salt hydrate - Citicoline - J64161 - Alfa Aesar

J64161 Cytidine-5'-diphosphocholine sodium salt hydrate

CAS-Nummer
33818-15-4
Synonyme
Citicoline

Größe Preis ($) Menge Verfügbarkeit
10g 61,20
25g 122,00
50g 220,00
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

Cytidine-5'-diphosphocholine sodium salt hydrate

MDL
MFCD00150508
EINECS
251-689-1

Chemische Eigenschaften

Formel
C14H26N4NaO11P2•xH2O
Molmasse
510.31(anhy)
Form
Powder
Löslichkeit
Soluble in water (100 mg/ml).

Anwendungen

Cytidine-5'-diphosphocholine sodium salt hydrate acts as a neuroprotective agent in situations of hypoxia and ischemia. It is used as biosynthetic intermediate of membrane phospholipids. It is a cerebral vasodilator and inhibits PLA2 activation.

Bemerkungen

Stable under recommended storage conditions. Incompatible with oxidizing agents.

Literaturverweise

W.M.Clark; S.J.Warach; L.C.Pettigrew; R.E.Gammans; L.A.Sabounjian. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology. 1997, 49,(3), 671-678.

 

S.Warach, MD, PhD; L.Creed Pettigrew, MD; J.F.Dashe, MD, PhD; P.Pullicino MD; David M.Lefkowitz, MD; L.Sabounjian, RN; K.Harnett, MS; U.Schwiderski, PhD; R.Gammans, PhD. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Annals of Neurology. 2000, 48,(5), 713-722.

Weitere Referenzen

Beilstein
4110040
Harmonized Tariff Code
2934.99
TSCA
No

Empfohlen

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf